IBA agrees to distribute Telix unit ARTMS’ QUANTM solid-target cyclotron technology worldwide

By Public Technologies
  • IBA signed an agreement with ARTMS, a Telix unit, to distribute the QUANTM Irradiation System solid-target cyclotron technology worldwide.
  • Deal positions IBA as a single supplier for cyclotron customers seeking installation and servicing of ARTMS’s solid-target capability.
  • Partnership targets scaled, decentralized production of radiometals used in theranostics, including validated gallium-68 and zirconium-89 output.
  • ARTMS will keep selling directly to existing customers; the system remains compatible with other cyclotron platforms.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. IBA - Ion Beam Applications SA published the original content used to generate this news brief on October 01, 2026, and is solely responsible for the information contained therein.

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.